CIK 0001705843 · Non-accelerated filer<br>Smaller reporting company
Cibus, Inc.
Sign in to watch- Ticker
- CBUS
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271967997
- Phone
- (858) 450-0008
- Business address
- 6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Former names
- Calyxt, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-09 | RIGGS RORY B Director | Option exercise | +4,000,000 | $0.00 | $400 | 14,533,307 |
| 2025-06-09 | RIGGS RORY B Director | Option exercise | +50,000 | $0.01 | $500 | 14,583,307 |
| 2025-06-09 | RIGGS RORY B Director | Option exercise · Pre-Funded Warrant (right to buy) | −4,000,000 | 0 | ||
| 2025-06-09 | RIGGS RORY B Director | Option exercise · Pre-Funded Warrant (right to buy) | −50,000 | 0 | ||
| 2025-06-05 | RIGGS RORY B Director | Grant or award | +5,714,286 | $1.75 | $10.0M | 10,533,307 |
| 2025-05-22 | Moretti August J Director | Grant or award · Stock Option (Right-to-Buy) | +39,301 | 39,301 | ||
| 2025-05-22 | Finn Mark Terrence Director | Grant or award · Stock Option (Right-to-Buy) | +39,301 | 39,301 | ||
| 2025-05-22 | Lehmann Jean-Pierre Jules Director | Grant or award | +32,490 | 32,490 | ||
| 2025-05-22 | Prante Gerhard Director | Grant or award | +32,490 | 40,197 | ||
| 2025-05-22 | RIGGS RORY B Director | Grant or award · Stock Option (Right-to-Buy) | +39,301 | 39,301 | ||
| 2025-05-22 | Walker Keith Allen Director | Grant or award · Stock Option (Right-to-Buy) | +39,301 | 39,301 | ||
| 2025-03-24 | Sauer Noel SVP, Research | Grant or award | +11,750 | 105,480 | ||
| 2025-03-24 | Sauer Noel SVP, Research | Grant or award · Stock Option (Right-to-Buy) | +23,500 | 23,500 | ||
| 2025-03-24 | Stokes Jason CLO, Gen Csl & Secy | Grant or award | +28,250 | 127,669 | ||
| 2025-03-24 | Stokes Jason CLO, Gen Csl & Secy | Grant or award · Stock Option (Right-to-Buy) | +56,500 | 56,500 | ||
| 2025-03-24 | Gocal Gregory Francis William Chief Scientific Officer & EVP | Grant or award | +60,000 | 374,844 | ||
| 2025-03-24 | Gocal Gregory Francis William Chief Scientific Officer & EVP | Grant or award · Stock Option (Right-to-Buy) | +119,500 | 119,500 | ||
| 2025-03-24 | Broos Carlo Interim CFO | Grant or award | +28,250 | 102,447 | ||
| 2025-03-24 | Broos Carlo Interim CFO | Grant or award · Stock Option (Right-to-Buy) | +56,500 | 56,500 | ||
| 2025-03-24 | Beetham Peter President and COO | Grant or award | +125,500 | 507,937 |
Page 3 of 7 · 139 trades